Skip to content
healthcare.dev

cilostazol

NDC 71610-813, cilostazol, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-813
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077030
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILOSTAZOL100 mg/1

Pharmacologic classes

Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]

Package NDCNDC-11Package
71610-813-26716100813261200 TABLET in 1 BOTTLE (71610-813-26)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/15478d90-312f-014e-e063-6294a90ae838

Use it

Look up 71610-813 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.